Study of Recombinant Human Insulin-Like Growth Factor I in Patients With Severe Insulin Resistance
Clinical trial NCT00004419 · COMPLETED
Trial details
- NCT number
- NCT00004419
- Sponsor
- Beth Israel Deaconess Medical Center
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 1998-04-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.